Search

Your search keyword '"Borger MA"' showing total 705 results
Start Over Author "Borger MA"
705 results on '"Borger MA"'

1. Pre-Implant Immune Status is Associated with Infection Risk After Left Ventricular Assist Device Implantation

Author

Dieterlen MT, Messer EK, Klaeske K, Sieg F, Eifert S, Haunschild J, Jawad K, Saeed D, Dashkevich A, and Borger MA

Subjects
lvad, immune system, t cells, b cells, plasmacytoid dendritic cells, neutrophil-lymphocyte ratio, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Maja-Theresa Dieterlen,&ast; Eva Katharina Messer,&ast; Kristin Klaeske, Franz Sieg, Sandra Eifert, Josephina Haunschild, Khalil Jawad, Diyar Saeed, Alexey Dashkevich,&ast; Michael Andrew Borger&ast; University Clinic of Cardiac Surgery, Leipzig Heart Center, HELIOS Clinic, Leipzig, Germany&ast;These authors contributed equally to this workCorrespondence: Maja-Theresa Dieterlen, University Department for Cardiac Surgery, Heart Center Leipzig, University Hospital, HELIOS Clinic, Strümpellstraße 39, Leipzig, 04289, Germany, Tel +49 – 341 865 1651, Fax +49 – 341 865 1452, Email mdieterlen@web.dePurpose: Infection is the most common complication after left ventricular assist device (LVAD) implantation. The immune status of LVAD patients is relevant for the incidence and severity of infection, but it is unknown if there is a predisposing immune status prior to LVAD implantation that contributes to an increased risk for infection in the post-implant period. We analyzed the pre-LVAD immune status in patients with infection within 3 months after LVAD implantation in comparison to infection-free patients.Patients and Methods: Fifty-four consecutive LVAD patients were included in this study. According to their infectious history in the first 3 months after LVAD implantation, these patients were grouped into an infection (n=23) and an infection-free group (n=31). Pre-LVAD blood samples were obtained for flow cytometric analysis of immunological parameters including B cells, subsets of T, dendritic and natural killer cells. Patient-specific, clinical and laboratory data were recorded.Results: Blood count analysis prior to LVAD implantation showed comparable counts of erythrocytes (p=0.19), platelets (p=0.33) and leukocytes (p=0.50) between patients with infection and infection-free patients in the post-implant period. Patients with infection in the first 3 months after LVAD implantation had lower concentrations of lymphocytes (p=0.02). Forty percent of the patients with infection showed more often pre-LVAD neutrophil-to-lymphocyte ratios (NLR) > 7 than patients without infection in the first 3 months after LVAD implantation (14%, p=0.05). Patients with infection already had lower percentages of CD3+ T cells (p=0.03), CD19+ B cells (p< 0.01), BDCA2+ pDCs (p=0.03) and BDCA4+ plasmacytoid DCs (pDCs) (p=0.05) prior to LVAD implantation than infection-free patients.Conclusion: Our results demonstrated that patients with infection in the early post-implant period showed lower concentrations of lymphocytes, especially of CD3+ T cells and CD19+ B cells, decreased percentages of BDCA2+ and BDCA4+ pDCs, and had more often NLRs > 7 indicating moderate-to-severe inflammation. Thus, we identified specific immunological changes pre-LVAD that could help to identify patients at risk for infection in the early post-implant period.Keywords: LVAD, immune system, T cells, B cells, plasmacytoid dendritic cells, neutrophil–lymphocyte ratio

Published
2024

3. Conventional Off-Pump Coronary Revascularization with Exclusive Bilateral Internal Mammary Arteries Versus Hybrid Coronary Revascularization, 10-Year Results.

Author

Gadelkarim, I., Shaqu, R., Otto, W., Misfeld, M., Davierwala, P., Borger, MA., and Verevkin, A.

Subjects
INTERNAL thoracic artery, PROPENSITY score matching
Abstract

This article compares the long-term outcomes of two different strategies for coronary revascularization: conventional off-pump total arterial revascularization with bilateral internal mammary arteries (BIMA) and hybrid coronary revascularization (HCR). The study retrospectively analyzed patients who received either BIMA (n = 542) or HCR (n = 123) at a single institute. After adjusting for baseline differences, the study found that patients who received BIMA had better 10-year survival and freedom from repeat revascularization compared to those who received HCR. However, the HCR group had a higher incidence of chronic obstructive lung disease, while the BIMA group had a higher incidence of three-vessel coronary artery disease and left main disease. Overall, the study suggests that for otherwise fit patients, conventional off-pump revascularization with BIMA may be the preferred strategy. [Extracted from the article]

Published
2024
Full Text
View/download PDF

4. Minimal Invasive Total Arterial Coronary Artery Bypass Grafting in Obese Patients.

Author

Shaqu, R., Gadelkarim, I., Otto, W., Davierwala, P., Misfeld, M., Borger, MA., and Verevkin, A.

Subjects
CORONARY artery bypass, ARTERIAL grafts, GASTRIC bypass, OBESITY
Abstract

This article discusses the use of Minimal Invasive Total Arterial Coronary Artery Bypass Grafting (MICS-CABG) as a surgical approach for treating coronary artery disease in obese patients. The study compared the outcomes of MICS-CABG in obese (BMI >30) and nonobese (BMI<30) patients. The results showed that MICS-CABG is safe and feasible for both obese and nonobese patients, with no significant differences in perioperative and mid-term outcomes. The authors conclude that obesity should not be an exclusion criterion for MICS-CABG in high volume centers. [Extracted from the article]

Published
2024
Full Text
View/download PDF

5. Durability of bioprosthetic aortic valve replacement in patients under the age of 60 years-1-year follow-up from the prospective INDURE registry

Author

Meuris, B, Roussel, JC, Borger, MA, Siepe, M, Stefano, P, Laufer, G, Langanay, T, Theron, A, Grabenwöger, M, Binder, K, Demers, P, Pessotto, R, van Leeuwen, W, Bourguignon, T, Canovas, S, Mariscalco, G, Coscioni, E, Dagenais, F, Wendler, O, Polvani, G, Eden, M, Botta, B, Bramlage, P, De Paulis, R, Meuris, B, Roussel, JC, Borger, MA, Siepe, M, Stefano, P, Laufer, G, Langanay, T, Theron, A, Grabenwöger, M, Binder, K, Demers, P, Pessotto, R, van Leeuwen, W, Bourguignon, T, Canovas, S, Mariscalco, G, Coscioni, E, Dagenais, F, Wendler, O, Polvani, G, Eden, M, Botta, B, Bramlage, P, and De Paulis, R

Abstract

OBJECTIVES: We report 1-year safety and clinical outcomes in patients <60 years undergoing bioprosthetic surgical aortic valve intervention. METHODS: The INSPIRIS RESILIA Durability Registry is a prospective, multicentre registry to assess clinical outcomes of patients <60 years. Patients with planned SAVR with or without concomitant replacement of the ascending aorta and/or coronary bypass surgery were included. Time-related valve safety, haemodynamic performance and quality of life (QoL) at 1 year were assessed. RESULTS: A total of 421 patients were documented with a mean age of 53.5 years, 76.5% being male and 27.2% in NYHA class III/IV. Outcomes within 30 days included cardiovascular-related mortality (0.7%), time-related valve safety (VARC-2; 5.8%), thromboembolic events (1.7%), valve-related life-threatening bleeding (VARC-2; 4.3%) and permanent pacemaker implantation (3.8%). QoL was significantly increased at 6 months and sustained at 1 year. Freedom from all-cause mortality at 1 year was 98.3% (95% confidence interval 97.1; 99.6) and 81.8% were NYHA I versus 21.9% at baseline. No patient developed structural valve deterioration stage 3 (VARC-3). The mean aortic pressure gradient was 12.6 mmHg at 1 year and the effective orifice area was 1.9 cm2. CONCLUSIONS: The 1-year data from the INSPIRIS RESILIA valve demonstrate good safety and excellent haemodynamic performance as well as an early QoL improvement. Clinical trial registration: clinicaltrials.gov: NCT03666741.

Published
2023

6. Stroke Complications in Patients Requiring Durable Mechanical Circulatory Support Systems After Extracorporeal Life Support

Author

Saeed, D, Loforte, A, Morshuis, M, Schibilsky, D, Zimpfer, D, Riebandt, J, Pappalardo, F, Attisani, M, Rinaldi, M, Haneya, A, Ramjankhan, F, Donker, Dw, Jorde, Up, Pacini, D, Otto, W, Stein, J, Lewin, D, Jawad, K, Wieloch, R, Ayala, R, Cremer, J, Borger, Ma, Lichtenberg, A, Gummert, J, Potapov, E, Durable MCS after ECLS Study, Group., Cardiovascular and Respiratory Physiology, and TechMed Centre

Subjects
Biomaterials, 2023 OA procedure, Biomedical Engineering, Biophysics, Bioengineering, General Medicine, ECMO, ECLS, mechanical circulatory support system, stroke
Abstract

Stroke is one of the leading complications following durable mechanical circulatory support (MCS) implantation. The aim of this multicenter study was to investigate stroke complications in patients requiring durable MCS following extracorporeal life support (ECLS). Data of 11 high volume MCS centers were collected and evaluated to identify patients who underwent durable MCS implantation after ECLS support between January 2010 and August 2018. The primary outcome was stroke following durable MCS implantation. Univariate and multivariate logistic regression analyses were performed to determine predictors of stroke. Overall, 531 patients met the inclusion criteria. Only patients who were supported with continuous flow pumps were included in this study accounting for 495 patients (median age 54 years old [interquartile range 47-60]). A total of 136 patients (27%) developed postoperative stroke on device during the follow-up (48% ischemic and 52% hemorrhagic) after a median durable MCS support of 320 [32-1,000] days, accounting for 0.17 events per patient-year. Of 133 patients with known date of stroke, a total of 47 (10%) developed stroke during the first 30 days (64% ischemic and 36% hemorrhagic), and 86 patients developed stroke after 30 days (38% ischemic and 62% hemorrhagic) of durable MCS support (late stroke). Survival rate was significantly lower in patients with hemorrhagic stroke (p = 0.00091). Stroke appears to be a common complication in patients transitioned to durable MCS support after ECLS. Hemorrhagic stroke is a more common type of late stroke and is associated with inferior outcomes.

Published
2022

7. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Author

Visseren, F, Mach, F, Smulders, Y, Carballo, D, Koskinas, K, Bäck, M, Benetos, A, Biffi, A, Boavida, J, Capodanno, D, Cosyns, B, Crawford, C, Davos, C, Desormais, I, Di Angelantonio, E, Franco, O, Halvorsen, S, Hobbs, F, Hollander, M, Jankowska, E, Michal, M, Sacco, S, Sattar, N, Tokgozoglu, L, Tonstad, S, Tsioufis, K, van Dis, I, van Gelder, I, Wanner, C, Williams, B, De Backer, G, Regitz-Zagrosek, V, Aamodt, A, Abdelhamid, M, Aboyans, V, Albus, C, Asteggiano, R, Borger, M, Brotons, C, Celutkiene, J, Cifkova, R, Cikes, M, Cosentino, F, Dagres, N, De Backer, T, De Bacquer, D, Delgado, V, Den Ruijter, H, Dendale, P, Drexel, H, Falk, V, Fauchier, L, Ference, B, Ferrières, J, Ferrini, M, Fisher, M, Fliser, D, Fras, Z, Gaita, D, Giampaoli, S, Gielen, S, Graham, I, Jennings, C, Jorgensen, T, Kautzky-Willer, A, Kavousi, M, Koenig, W, Konradi, A, Kotecha, D, Landmesser, U, Lettino, M, Lewis, B, Linhart, A, Lochen, M, Makrilakis, K, Mancia, G, Marques-Vidal, P, Mcevoy, J, Mcgreavy, P, Merkely, B, Neubeck, L, Nielsen, J, Perk, J, Petersen, S, Petronio, A, Piepoli, M, Pogosova, N, Prescott, E, Ray, K, Reiner, Z, Richter, D, Rydén, L, Shlyakhto, E, Sitges, M, Sousa-Uva, M, Sudano, I, Tiberi, M, Touyz, R, Ungar, A, Verschuren, W, Wiklund, O, Wood, D, Zamorano, J, Visseren, FLJ, Smulders, YM, Koskinas, KC, Boavida, JM, Davos, CH, Franco, OH, Hobbs, FDR, Jankowska, EA, Tsioufis, KP, van Gelder, IC, Aamodt, AH, Borger, MA, Ference, BA, Lewis, BS, Lochen, ML, McEvoy, JW, McGreavy, P, Nielsen, JC, Petersen, SE, Petronio, AS, Pogosova, NG, Prescott, EIB, Ray, KK, Richter, DJ, Touyz, RM, Verschuren, WMM, Zamorano, JL, Visseren, F, Mach, F, Smulders, Y, Carballo, D, Koskinas, K, Bäck, M, Benetos, A, Biffi, A, Boavida, J, Capodanno, D, Cosyns, B, Crawford, C, Davos, C, Desormais, I, Di Angelantonio, E, Franco, O, Halvorsen, S, Hobbs, F, Hollander, M, Jankowska, E, Michal, M, Sacco, S, Sattar, N, Tokgozoglu, L, Tonstad, S, Tsioufis, K, van Dis, I, van Gelder, I, Wanner, C, Williams, B, De Backer, G, Regitz-Zagrosek, V, Aamodt, A, Abdelhamid, M, Aboyans, V, Albus, C, Asteggiano, R, Borger, M, Brotons, C, Celutkiene, J, Cifkova, R, Cikes, M, Cosentino, F, Dagres, N, De Backer, T, De Bacquer, D, Delgado, V, Den Ruijter, H, Dendale, P, Drexel, H, Falk, V, Fauchier, L, Ference, B, Ferrières, J, Ferrini, M, Fisher, M, Fliser, D, Fras, Z, Gaita, D, Giampaoli, S, Gielen, S, Graham, I, Jennings, C, Jorgensen, T, Kautzky-Willer, A, Kavousi, M, Koenig, W, Konradi, A, Kotecha, D, Landmesser, U, Lettino, M, Lewis, B, Linhart, A, Lochen, M, Makrilakis, K, Mancia, G, Marques-Vidal, P, Mcevoy, J, Mcgreavy, P, Merkely, B, Neubeck, L, Nielsen, J, Perk, J, Petersen, S, Petronio, A, Piepoli, M, Pogosova, N, Prescott, E, Ray, K, Reiner, Z, Richter, D, Rydén, L, Shlyakhto, E, Sitges, M, Sousa-Uva, M, Sudano, I, Tiberi, M, Touyz, R, Ungar, A, Verschuren, W, Wiklund, O, Wood, D, Zamorano, J, Visseren, FLJ, Smulders, YM, Koskinas, KC, Boavida, JM, Davos, CH, Franco, OH, Hobbs, FDR, Jankowska, EA, Tsioufis, KP, van Gelder, IC, Aamodt, AH, Borger, MA, Ference, BA, Lewis, BS, Lochen, ML, McEvoy, JW, McGreavy, P, Nielsen, JC, Petersen, SE, Petronio, AS, Pogosova, NG, Prescott, EIB, Ray, KK, Richter, DJ, Touyz, RM, Verschuren, WMM, and Zamorano, JL

Published
2022

10. Durability of bioprosthetic aortic valves in patients under the age of 60years-rationale and design of the international INDURE registry

Author

Meuris, B, Borger, MA, Bourguignon, T, Siepe, M, Grabenwoger, M, Laufer, G, Binder, K, Polvani, G, Di Stefano, P, Coscioni, E, van Leeuwen, Wouter, Demers, P, Dagenais, F, Canovas, S, Theron, A, Langanay, T, Roussel, JC, Wendler, O, Mariscalco, G, Pessotto, R, Botta, B, Bramlage, P, De Paulis, R, Meuris, B, Borger, MA, Bourguignon, T, Siepe, M, Grabenwoger, M, Laufer, G, Binder, K, Polvani, G, Di Stefano, P, Coscioni, E, van Leeuwen, Wouter, Demers, P, Dagenais, F, Canovas, S, Theron, A, Langanay, T, Roussel, JC, Wendler, O, Mariscalco, G, Pessotto, R, Botta, B, Bramlage, P, and De Paulis, R

Published
2020

11. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Working Group of the European Society of Cardiology (ESC) to conduct affairs in acute coronary syndromes without ST segment elevation of persistent

Author

Roffi, M, Patrono, C, Collet, JP, Mueller, C, Valgimigli, Marco, Andreotti, F, Bax, JJ, Borger, MA, Brotons, C, Chew, DP, Gencer, B, Hasenfuss, G, Kjeldsen, K, Lancellotti, P, Landmesser, U, Mehilli, J, Mukherjee, D, Storey, RF, Windecker, S, and Cardiology

Published
2015

13. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Author

Roffi, M, PATRONO, CARLO, Collet, J, Mueller, C, Valgimigli, M, ANDREOTTI, FELICITA, Bax, JJ, Borger, MA, Brotons, C, Chew, DP, Gencer, B, Hasenfuss, G, Kjeldsen, K, Lancellotti, P, Landmesser, U, Mehilli, J, Mukherjee, D, Storey, RF, Windecker, S, Baumgartner, H, Gaemperli, O, Achenbach, S, Agewall, S, Badimon, L, Baigent, C, Bueno, H, Bugiardini, R, Carerj, S, Casselman, F, Cuisset, T, Erol, Ç, Fitzsimons, D, Halle, M, Hamm, C, Hildick-Smith, D, Huber, K, Iliodromitis, E, James, S, Lewis, BS, Lip, GYH, Piepoli, MF, Richter, D, Rosemann, T, Sechtem, U, Steg, PG, Vrints, C, Luis Zamorano, J, Roffi, M, PATRONO, CARLO, Collet, J, Mueller, C, Valgimigli, M, ANDREOTTI, FELICITA, Bax, JJ, Borger, MA, Brotons, C, Chew, DP, Gencer, B, Hasenfuss, G, Kjeldsen, K, Lancellotti, P, Landmesser, U, Mehilli, J, Mukherjee, D, Storey, RF, Windecker, S, Baumgartner, H, Gaemperli, O, Achenbach, S, Agewall, S, Badimon, L, Baigent, C, Bueno, H, Bugiardini, R, Carerj, S, Casselman, F, Cuisset, T, Erol, Ç, Fitzsimons, D, Halle, M, Hamm, C, Hildick-Smith, D, Huber, K, Iliodromitis, E, James, S, Lewis, BS, Lip, GYH, Piepoli, MF, Richter, D, Rosemann, T, Sechtem, U, Steg, PG, Vrints, C, and Luis Zamorano, J

Published
2016

14. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Author

Vahanian, A, Alfieri, O, Andreotti, F, Antunes, Mj, Barón Esquivias, G, Baumgartner, H, Borger, Ma, Carrel, Tp, De Bonis, M, Evangelista, A, Falk, V, Iung, B, Lancellotti, P, Pierard, L, Price, S, Schäfers, Hj, Schuler, G, Stepinska, J, Swedberg, K, Takkenberg, J, Von Oppell UO, Windecker, S, Zamorano, Jl, Zembala, M, ESC Committee for Practice Guidelines, Bax, Jj, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Document, Reviewers, Von Segesser, L, Badano, Lp, Bunc, M, Claeys, Mj, Drinkovic, N, Filippatos, G, Habib, G, Kappetein, Ap, Kassab, R, Lip, Gy, Moat, N, Nickenig, G, Otto, Cm, Pepper, J, Piazza, N, Pieper, Pg, Rosenhek, R, Shuka, N, Schwammenthal, E, Schwitter, J, Mas, Pt, Trindade, Pt, and Walther, T.

Subjects
NO
Published
2012

15. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Author

Steg, Pg, James, Sk, Atar, D, Badano, Lp, Lundqvist, Cb, Borger, Ma, Di Mario, C, Dickstein, K, Ducrocq, G, Fernandez Aviles, F, Gershlick, Ah, Giannuzzi, P, Halvorsen, S, Huber, K, Juni, P, Kastrati, A, Knuuti, J, Lenzen, Mj, Mahaffey, Kw, Valgimigli, M, Van't Hof, A, Widimsky, P, Zahger, D, ESC Committee for Practice Guidelines, Bax, Jj, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Astin, F, Aström Olsson, K, Budaj, A, Clemmensen, P, Collet, Jp, Fox, Ka, Fuat, A, Gustiene, O, Hamm, Cw, Kala, P, Lancellotti, P, Maggioni, Ap, Merkely, B, Neumann, Fj, Piepoli, Mf, Van de Werf, F, Verheugt, F, Wallentin, L., Steg, P, James, S, Atar, D, Badano, L, Lundqvist, C, Borger, M, Di Mario, C, Dickstein, K, Ducrocq, G, Fernandez-Aviles, F, Gershlick, A, Giannuzzi, P, Halvorsen, S, Huber, K, Juni, P, Kastrati, A, Knuuti, J, Lenzen, M, Mahaffey, K, Valgimigli, M, Van'T Hof, A, Widimsky, P, Zahger, D, Bax, J, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck-Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, B, Reiner, Z, Sechtem, U, Sirnes, P, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Astin, F, Astrom-Olsson, K, Budaj, A, Clemmensen, P, Collet, J, Fox, K, Fuat, A, Gustiene, O, Hamm, C, Kala, P, Lancellotti, P, Maggioni, A, Merkely, B, Neumann, F, Piepoli, M, Van De Werf, F, Verheugt, F, and Wallentin, L

Subjects
Emergency Medical Services, Biomedical Research, General Practice, Myocardial Infarction, Guideline, Anxiety, ST-segment elevation, Electrocardiography, Myocardial infarction, Coronary Artery Bypass, 610 Medicine & health, Fibrinolytic Agent, Cardiovascular diseases [NCEBP 14], Secondary prevention, General Medicine, Reperfusion therapy, Antifibrinolytic Agents, Exercise Therapy, Hospitalization, cardiovascular system, Cardiology, Acute coronary syndromes Ischaemic heart disease, Cardiomyopathies, Cardiology and Cardiovascular Medicine, Ticagrelor, Human, medicine.drug, Acute coronary syndrome, medicine.medical_specialty, Cardiotonic Agents, Pain, Myocardial Reperfusion, Acute myocardial infarction, Guidelines, Antifibrinolytic Agent, Risk Assessment, Time-to-Treatment, Percutaneous Coronary Intervention, Fibrinolytic Agents, Internal medicine, medicine, Humans, Cardiotonic Agent, Hemodynamic, cardiovascular diseases, Emergency Treatment, Cardiomyopathie, Heart Failure, Cardiac Imaging Technique, Management of acute coronary syndrome, Emergency Medical Service, business.industry, Coronary Artery Bypa, Platelet Aggregation Inhibitor, Hemodynamics, Arrhythmias, Cardiac, MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE, medicine.disease, Long-Term Care, Primary percutaneous coronary intervention Antithrombotic therapy, Cardiac Imaging Techniques, Dyspnea, Hyperglycemia, Door-to-balloon, Myocardial infarction complications, Myocardial infarction diagnosis, business, Risk Reduction Behavior, Platelet Aggregation Inhibitors, Out-of-Hospital Cardiac Arrest, Forecasting
Abstract

ACE : angiotensin-converting enzyme ACS : acute coronary syndrome ADP : adenosine diphosphate AF : atrial fibrillation AMI : acute myocardial infarction AV : atrioventricular AIDA-4 : Abciximab Intracoronary vs. intravenously Drug Application APACHE II : Acute Physiology Aand Chronic

Published
2012

50. Transapical aortic valve implantation at 5 years

Author

Haensig, M, primary, Rastan, AJ, additional, Holzhey, DM, additional, Walther, T, additional, Garbade, J, additional, Borger, MA, additional, Linke, A, additional, Ender, J, additional, Schuler, G, additional, Kempfert, J, additional, and Mohr, FW, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results